A Study of Aplidin (Plitidepsin) 3 h iv in Subjects With Relapsing or Refractory Multiple Myeloma

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions

Multiple Myeloma

Interventions

DRUG

Plitidepsin

3-hour infusion every 2 weeks alone or in combination with dexamethasone

Trial Locations (1)

Jerome Lipper Multiple Myeloma Center - Dept of Medical Oncology - Dana Farber Cancer Institute, Boston